Literature DB >> 19688858

Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.

Zhong-He Wang1, Chao Yan, Zhi-Yuan Zhang, Chen-Ping Zhang, Hai-Sheng Hu, Jessica Kirwan, William M Mendenhall.   

Abstract

OBJECTIVES/HYPOTHESIS: To investigate changes in parotid and submandibular gland volumes of patients with head and neck cancer treated with postoperative intensity-modulated radiotherapy (IMRT) or conventional radiotherapy (CRT), and to relate the volume changes to different mean radiation therapy (RT) doses to the parotid and submandibular glands.
METHODS: Between May 2007 and May 2008, 82 head and neck cancer patients (oral cavity cancer, 71; oropharynx cancer, 11) were treated with surgery and postoperative RT (IMRT, 40; CRT, 42) at our institution. Every patient underwent four computed tomography (CT) scans: one before RT, one after 3 weeks or at the 15th fraction of RT, one upon completing RT, and one at 2 months after RT; 39 of 82 patients had an additional CT scan at 6 months after RT. A dose-volume histogram was used to evaluate the mean volumes of patients' parotid and submandibular glands and mean RT doses to the glands on every CT scan. Altogether, 241 salivary glands (parotid, 162; submandibular, 79) were analyzed. The volume changes of the glands were evaluated against three levels of mean gland doses: <30 Gy, 30 to 50 Gy, and >50 Gy.
RESULTS: The mean RT doses to spared parotid glands, spared submandibular glands, and irradiated submandibular glands in patients treated with IMRT were 22.21 Gy, 18.26 Gy, and 52.19 Gy, respectively. The mean doses to parotid and submandibular glands in patients treated with CRT were 50.22 Gy and 62.09 Gy, respectively. The average volume loss rates in parotid glands after 3 weeks of RT, at the end of RT, and 2 months after RT versus before RT were 20.01%, 26.93%, and 27.21%, respectively. The average volume loss rates in submandibular glands after 3 weeks of RT, at the end of RT, and 2 months after RT versus before RT was 11.49%, 16.76%, and 16.29%, respectively. Parotid and submandibular glands did not continue to shrink after completing RT. We observed more volume loss during RT in the parotid glands than in the submandibular glands. The average rates of volume loss during the first 3 weeks of RT (20.01% and 11.49%, respectively) were larger than in the last 3 weeks of RT (8.57% and 6.0%, respectively). No significant differences were observed in the mean volumes of both parotid and submandibular glands between the end of RT, 2 months post-RT, and 6 months post-RT (P > .05). Volume loss at higher doses (>30 Gy) to the glands was significantly larger than at low doses (<30 Gy; P < .001).
CONCLUSIONS: The parotid and submandibular glands shrunk during RT, but the parotid glands shrunk more than the submandibular glands. These gland volume reductions correlated significantly with the mean dose to the irradiated glands; the spared glands showed few changes.

Entities:  

Mesh:

Year:  2009        PMID: 19688858     DOI: 10.1002/lary.20601

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  31 in total

Review 1.  Current progress in adaptive radiation therapy for head and neck cancer.

Authors:  David L Schwartz
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

2.  Biomechanical modeling of radiation dose-induced volumetric changes of the parotid glands for deformable image registration.

Authors:  Molly M McCulloch; Guillaume Cazoulat; Alexandra C Ford; Baher Elgohari; Houda Bahig; Andrew D Kim; Hesham Elhalawani; Renjie He; Jihong Wang; Yao Ding; Abdallah Sr Mohamed; Daniel F Polan; Jason B King; Christine B Peterson; Andrea N Ohrt; Clifton D Fuller; Stephen Y Lai; Kristy K Brock
Journal:  Phys Med Biol       Date:  2020-08-31       Impact factor: 3.609

3.  Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy.

Authors:  G Sanguineti; F Ricchetti; O Thomas; B Wu; T McNutt
Journal:  Br J Radiol       Date:  2013-09-12       Impact factor: 3.039

Review 4.  Adaptive radiation therapy in head and neck cancer for clinical practice: state of the art and practical challenges.

Authors:  Ovidiu Veresezan; Idriss Troussier; Alexis Lacout; Sarah Kreps; Sophie Maillard; Aude Toulemonde; Pierre-Yves Marcy; Florence Huguet; Juliette Thariat
Journal:  Jpn J Radiol       Date:  2016-12-01       Impact factor: 2.374

Review 5.  Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature.

Authors:  S W Loo; W M C Martin; P Smith; S Cherian; T W Roques
Journal:  Br J Radiol       Date:  2012-08       Impact factor: 3.039

6.  Submandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma.

Authors:  L Huang; W Zhang; T Zhuang; F Wu; D Li; M Zheng; B Lin; M Zhuang; Z Chen
Journal:  Br J Radiol       Date:  2014-02-07       Impact factor: 3.039

7.  The protective effects of different treatments on rat salivary glands after radiotherapy.

Authors:  Murat Konak; Hakan Cincik; Evren Erkul; Zafer Kucukodaci; Atila Gungor; Sevim Ozdemir; Engin Cekin; Volkan Arisan; Mesut Mutluoglu; Murat Salihoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-20       Impact factor: 2.503

8.  Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma.

Authors:  V W C Wu; M T C Ying; D L W Kwong
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

9.  Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.

Authors:  B Nabaa; K Takahashi; T Sasaki; A Okizaki; T Aburano
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-03       Impact factor: 3.825

10.  Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard?

Authors:  David L Schwartz; Lei Dong
Journal:  J Oncol       Date:  2010-08-18       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.